We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Acceleron Pharma Inc (XLRN) USD0.001

Sell:$173.95 Buy:$174.86 Change: $0.20 (0.12%)
Market closed |  Prices as at close on 22 October 2021 | Switch to live prices |
Tender Offer

Acceleron Pharma Inc USD0.001

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 20 Oct 2021)

Acceleron Pharma Inc and Merck & Co Inc have recently announced that they have entered into a definitive agreement under which Merck & Co Inc will acquire Acceleron Pharma Inc. Merck & Co Inc has now opened a tender offer as the first stage of completing the takeover. You have been offered USD180.00 for each share held.

 

If you don’t want to accept the offer you don’t have to do anything. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining shares at a later date.

 

Accept the offer below – Act by noon Thursday 4 November 2021

  

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$173.95
Buy:$174.86
Change: $0.20 (0.12%)
Market closed |  Prices as at close on 22 October 2021 | Switch to live prices |
Tender Offer

Acceleron Pharma Inc USD0.001

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 20 Oct 2021)

Acceleron Pharma Inc and Merck & Co Inc have recently announced that they have entered into a definitive agreement under which Merck & Co Inc will acquire Acceleron Pharma Inc. Merck & Co Inc has now opened a tender offer as the first stage of completing the takeover. You have been offered USD180.00 for each share held.

 

If you don’t want to accept the offer you don’t have to do anything. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining shares at a later date.

 

Accept the offer below – Act by noon Thursday 4 November 2021

  

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$173.95
Buy:$174.86
Change: $0.20 (0.12%)
Market closed |  Prices as at close on 22 October 2021 | Switch to live prices |
Tender Offer

Acceleron Pharma Inc USD0.001

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 20 Oct 2021)

Acceleron Pharma Inc and Merck & Co Inc have recently announced that they have entered into a definitive agreement under which Merck & Co Inc will acquire Acceleron Pharma Inc. Merck & Co Inc has now opened a tender offer as the first stage of completing the takeover. You have been offered USD180.00 for each share held.

 

If you don’t want to accept the offer you don’t have to do anything. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining shares at a later date.

 

Accept the offer below – Act by noon Thursday 4 November 2021

  

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Performance

Not available for this stock.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Past performance is not an indication of future performance. The value of investments and any income from them is not guaranteed and can go down as well as up depending on market movements. You may not get back the original amount invested. Charts provided by Factset. Prices delayed by at least 15 minutes.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.